Glucomannan Related Medical Research
Diabetes
- Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus.
- Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. {pdf format}
- Long-term effects of dietary fiber supplementation on serum glucose and lipoprotein levels in diabetic rats fed a high cholesterol diet.
- Dietary fiber in the dietetic therapy of diabetes mellitus. Experimental data with purified glucomannans
- Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. {pdf format}
- Effect of Konjac food on blood glucose level in patients with diabetes.
- Effects of long-term high-fiber diet on macrovascular changes and lipid and glucose levels in STZ-induced diabetic SD rats.
Cholesterol
- Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men.
- Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats.
- Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed "Western" diets.
- Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption.
- Antisteatotic effects of four kinds of dietary fibers in rats fed on high cholesterol diet: a preliminary morphometric analysis
- Effects of dietary konjac mannan on serum and liver cholesterol levels and biliary bile acid composition in hamsters.
- Influences of refined konjac meal on the levels of tissue lipids and the absorption of four minerals in rats.
Obesity
- Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients
- Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo.
- The use of highly purified glucomannan-based fibers in childhood obesity
- Chronic use of glucomannan in the dietary treatment of severe obesity
- Effect of glucomannan on obese patients: a clinical study.
Constipation
- Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children.
- A clinical study of the use of a combination of glucomannan with lactulose in the constipation of pregnancy
- Action of glucomannans on complaints in patients affected with chronic constipation: a multicentric clinical evaluation.
- Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan.
Colonic pathology
- Purification and characterization of konjac glucomannan degrading enzyme from anaerobic human intestinal bacterium, Clostridium butyricum-Clostridium beijerinckii group.
- Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial.
- Use of glucomannan dietary fiber in changes in intestinal habit
- Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group.
Others
- Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery.
- Dietary fiber and OGTT: blood sugar variations after administration of a new purified glucomannane
- Long-term animal feeding trial of the refined konjac meal. II. Effects of the refined konjac meal on the aging of the brain, liver, and cardiovascular tissue cells in rats.
- Inhibitory effect of refined Amorphophallus konjac on MNNG-induced lung cancers in mice
- Immunologic clinical evaluation of a biological response modifier, AM3, in the treatment of childhood infectious respiratory pathology